Posted inGenetics
Synaffix and Sidewinder Agree to Advance Next-Generation Bispecific ADC Development
Synaffix, a Lonza company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs), and Sidewinder…









